Skip to the page

Data / Drug companies / For suspension

Companies that list for suspension products: 38 companies and 83 products in the FDA NDC directory

The FDA National Drug Code Directory lists 83 products that are for suspension products from 38 companies. The ten largest listers hold 57.8% of them, and the newest started marketing on October 9, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies
38
Products
83
Drugs by generic name
22
Main marketing category
Generic drugs (ANDA)

Companies that list for suspension products

Ranked by number of products in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
NuCare Pharmaceuticals,Inc.7for suspensionGeneric drugs (ANDA)April 1, 2024
Bryant Ranch Prepack6for suspensionGeneric drugs (ANDA)March 28, 2019
A-S Medication Solutions5for suspensionGeneric drugs (ANDA)March 28, 2019
Ajanta Pharma USA Inc.5for suspensionGeneric drugs (ANDA)February 9, 2023
Cipla USA Inc.5for suspensionGeneric drugs (ANDA)January 7, 2025
Preferred Pharmaceuticals Inc.5for suspensionGeneric drugs (ANDA)June 3, 2024
USAntibiotics, LLC5for suspensionAuthorized generics (NDA)April 1, 2024
Bryant Ranch Prepack4for suspensionGeneric drugs (ANDA)November 21, 2022
Bryant Ranch Prepack3for suspensionGeneric drugs (ANDA)March 28, 2019
Lupin Pharmaceuticals, Inc.3for suspensionGeneric drugs (ANDA)September 6, 2017
Ascend Laboratories, LLC2for suspensionGeneric drugs (ANDA)March 28, 2019
Cadila Pharmaceuticals Limited2for suspensionGeneric drugs (ANDA)November 21, 2022
Harrow Eye, LLC2for suspensionNew drug applications (NDA)April 7, 2025
Kanchan Healthcare Inc2for suspensionGeneric drugs (ANDA)November 21, 2022
Remedyrepack Inc.2for suspensionAuthorized generics (NDA)December 2, 2025
Sandoz Inc2for suspensionGeneric drugs (ANDA)September 4, 2007
Strides Pharma Science Limited2for suspensionGeneric drugs (ANDA)February 2, 2024
Alembic Pharmaceuticals Inc.1for suspensionGeneric drugs (ANDA)June 29, 2026
Alembic Pharmaceuticals Limited1for suspensionGeneric drugs (ANDA)June 29, 2026
Allegis Holdings, LLC1for suspensionNew drug applications (NDA)September 1, 2023
American Health Packaging1for suspensionGeneric drugs (ANDA)August 1, 2023
Amneal Pharmaceuticals NY LLC1for suspensionGeneric drugs (ANDA)March 5, 2018
Amneal Pharmaceuticals of New York LLC1for suspensionGeneric drugs (ANDA)January 20, 2023
Ani Pharmaceuticals, Inc.1for suspensionGeneric drugs (ANDA)May 31, 2019
Asclemed USA Inc.1for suspensionAuthorized generics (NDA)April 1, 2024
AvKARE1for suspensionGeneric drugs (ANDA)August 26, 2019
Camber Pharmaceuticals, Inc.1for suspensionGeneric drugs (ANDA)May 11, 2021
Dr. Reddy's Laboratories Inc.1for suspensionGeneric drugs (ANDA)March 15, 2024
Exelan Pharmaceuticals Inc.1for suspensionGeneric drugs (ANDA)December 1, 2023
La Jolla Pharmaceutical Company1for suspensionNew drug applications (NDA)October 9, 2026
Lupin Pharmaceuticals, Inc.1for suspensionGeneric drugs (ANDA)September 29, 2025
Lupin Pharmaceuticals,Inc.1for suspensionGeneric drugs (ANDA)December 17, 2012
Macleods Pharmaceuticals Limited1for suspensionGeneric drugs (ANDA)July 11, 2025
Proficient Rx LP1for suspensionGeneric drugs (ANDA)September 6, 2017
Redpharm Drug1for suspensionAuthorized generics (NDA)September 19, 2022
Somerset Therapeutics, LLC1for suspensionGeneric drugs (ANDA)February 26, 2025
Virtus Pharmaceuticals, LLC1for suspensionGeneric drugs (ANDA)August 2, 2021
Zydus Pharmaceuticals USA Inc.1for suspensionGeneric drugs (ANDA)September 14, 2017

Drugs most often listed

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.